Cellular Therapeutics for Heart Failure: Focus on Mesenchymal Stem Cells
Resulting from a various etiologies, the most notable remains ischemia; heart failure (HF) manifests as the common end pathway of many cardiovascular processes and remains among the top causes for hospitalization and a major cause of morbidity and mortality worldwide. Current pharmacologic treatment...
Saved in:
| Main Authors: | Amitabh C. Pandey, Jordan J. Lancaster, David T. Harris, Steven Goldman, Elizabeth Juneman |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2017-01-01
|
| Series: | Stem Cells International |
| Online Access: | http://dx.doi.org/10.1155/2017/9640108 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mesenchymal Stem Cells in Myeloid Malignancies: A Focus on Immune Escaping and Therapeutic Implications
by: Nicola Stefano Fracchiolla, et al.
Published: (2017-01-01) -
Precision medicine in premature ovarian insufficiency: a focus on the precision therapeutic strategies for mesenchymal stem cells
by: Rou Wang, et al.
Published: (2025-07-01) -
Therapeutic Efficiency of Nasal Mucosa-Derived Ectodermal Mesenchymal Stem Cells in Rats with Acute Hepatic Failure
by: Wen Xiang, et al.
Published: (2023-01-01) -
Classification of heart failure: focus on prevention
by: E. V. Shlyakhto
Published: (2023-02-01) -
Indications for heart transplantation: focus on advanced heart failure
by: V. F. Petrov, et al.
Published: (2024-10-01)